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ABSTRACT 
 
 
 
Lee, Joonyong M.S., Purdue University, August 2014. The function of Ascl1 in 
pregnancy-induced maternal liver growth. Major Professor: Guoli Dai. 
 
 
 
The maternal liver shows marked growth during pregnancy to accommodate the 
development and metabolic needs of the placenta and fetus. Previous study has shown 
that the maternal liver grows proportionally to the increase in body weight during 
gestation by hyperplasia and hypertrophy of hepatocytes. As the maternal liver is 
enlarged, the transcript level of Ascl1, a transcription factor essential to progenitor cells 
of the central nervous system and peripheral nervous system, is highly upregulated. The 
aims of the study were to (1) identify hepatic Ascl1-expressing cells, and (2) study the 
functions of Ascl1 in maternal liver during pregnancy. In situ hybridization shows that 
most cell types (parenchymal, nonparenchymal, and mesothelial cells) express Ascl1 
mRNA in maternal livers during gestation and in male regenerating livers. Notably, 
hepatic mesothelial cells abundantly express Ascl1 during pregnancy and liver 
regeneration. Inducible ablation of Ascl1 gene during pregnancy results in maternal liver 
enlargement, litter size reduction, and fetal growth retardation. In addition, maternal 
hepatocytes deficient in Ascl1 gene lack majority of their cytosols and exhibit β-catenin 
nuclear translocation, while maintaining their cellular boundary and identity. In summary, 
in both maternal liver during pregnancy and regenerating liver, the expression of Ascl1 is
viii 
induced in most cell types. Mesothelial cells are potential origin of Ascl1-expressing cells. 
Ascl1 gene is essential for the progression of normal pregnancy. 
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CHAPTER 1. INTRODUCTION 
 
 
 
1.1 Objective 
 
 
 
The objectives of the study were to identify hepatic Ascl1-expressing cells, and 
study the functions of Ascl1 in maternal liver during pregnancy. 
 
 
1.2 Background 
 
 
 
1.2.1 Anatomy and function of the liver 
 
Liver maintains homeostasis of the body via metabolism of carbohydrate, fat, and 
protein, storage of vitamins, processing of drugs and xenobiotics, and production of 
exocrine, bile acid, and bilirubin (Hill, 2009). Hepatocytes, the parenchymal cells of the 
liver, perform the majority of these vital functions and comprise about 80% of liver 
weight and 70% of total number of liver cells (Si-Tayeb et al., 2010). Fenestrated hepatic 
sinusoidal endothelial cells line hepatocytes and provide vascular supply from portal vein 
and hepatic artery, which flow into central vein. Hepatocytes secrete bile into bile 
canaliculi, which travels into bile ducts. The nonparenchymal cells of the liver are biliary 
epithelial cells, sinusoidal endothelial cells, Kupffer cells, pit cells, and hepatic stellate 
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cells. Biliary epithelial cells, or cholangiocytes, line bile ducts. Hepatic macrophages, 
also known as Kupffer cells, and hepatic natural killer cells, also called pit cells, play a 
role in liver defense mechanisms (Parker et al., 2012). Hepatic stellate cells, a population 
of hepatic fat storing cells, inhabit in the space of Disse, a perisinusoidal space between 
hepatocytes and sinusoidal endothelial cells (Friedman et al., 2008). Hence, the liver is 
comprised of heterogeneous populations of hepatic cells that maintain homeostatic 
balance. 
 
 
1.2.2 Pregnancy-induced maternal liver growth 
 
Various parts of maternal organs, such as pancreatic beta cells (Nielsen et al., 
1999; Kim et al., 2010), forebrain subventricular zone (Shingo et al., 2003), and spleen 
(Bustamante et al., 2008), need to adapt to pregnancy for accommodating the 
development and metabolic needs of the placenta and fetus. The maternal liver shows 
marked growth during pregnancy (Bustamante et al., 2010). Proportional to the increase 
in body weight from the growth of fetus and placenta, the maternal liver grows 80% in 
size and doubles the weight by hyperplasia and hypertrophy of hepatocytes (Dai et al., 
2011). The liver weight reverts to prepregnancy state after parturition. The maternal liver 
activates genes associated with liver growth and regeneration (cyclins A2, D1, and E, c-
Jun, IL1β, IL6, and TNFα). Recent investigation shows that Nrf2, a transcription factor 
that regulates liver regeneration (Beyer et al., 2008; Wakabayashi et al., 2010), is 
required for normal maternal liver adaptation in response to pregnancy (Zou et al., 2013). 
Thus, maternal liver growth and liver regeneration may hold common themes. 
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1.2.3 Liver regeneration 
 
The liver has a high capacity to regenerate from injuries. A model for acute liver 
injury is 2/3 partial hepatectomy (PHx). The mouse liver has five lobes (right and left 
medial lobes, right and left lateral lobes, and caudate lobe) and PHx is the surgical 
removal of right and left medial lobes and left lateral lobe (Mitchell and Willenbring, 
2008). Hepatocytes have a slow turnover rate. In normal homeostatic environment, 
mature hepatocytes have a lifespan of 191 to 453 days (MacDonald, 1961) and divide 
twice in 300 days (Magami et al., 2002). However, hepatocytes undergo hypertrophy and 
hyperplasia to restore the normal liver-to-body weight ratio (~5%) after PHx (Miyaoka 
and Miyajima, 2013). Hepatocytes increase in cell size by 1.6-fold and 40% of 
hepatocytes undergo cell division to restore liver mass within 1 to 2 weeks after PHx. The 
current consensus is that only residual liver cells participate in liver regeneration after 
PHx and does not involve liver progenitor cells. 
When the self-renewal capacity of hepatocytes is insufficient or blocked, liver 
progenitor cells (LPCs) take over to restore the liver. Chronic liver injuries, such as 
injuries induced by dipin (Factor et al., 1994), 3,5-diethoxycarbonyl-1,4-dihidro-collidine 
(DDC) (Preisegger et al., 1999), and high-fat diet with ethanol (Jung et al., 2008), 
activate proliferation and differentiation of LPCs. Small and oval shaped LPCs reside in 
the canal of Hering, the intermediate junction between hepatocytes and biliary epithelial 
cells (Paku et al., 2001). Cellular markers used for isolating LPCs are CD133, CD13, and 
Epcam in normal, acutely injured, and chronically injured adult livers (Rountree et al., 
2007; Kamiya et al., 2009; Okabe et al., 2009). LPCs have high clonogenic properties, 
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the capability to differentiate into hepatocytes and biliary epithelial cells, and the ability 
to repopulate liver cells (Kamiya et al., 2009). However, bidirectional differentiations of 
LPCs into hepatocytes and biliary epithelial cells in vivo remain elusive. 
 
 
1.2.4 Achaete-scute complex homolog 1 
 
Cytogenetically located on chromosome 10, at 10 C1 in mouse, achaete-scute 
homolog 1 (Ascl1 – Mouse Genome Informatics), formally known as mammalian 
achaete-scute homolog 1 (Mash1), is a member of the basic helix-loop-helix (bHLH) 
family of transcription factors that regulate neurogenesis and gliogenesis during 
development (Bertrand et al., 2002; Ross et al., 2003). The length of Ascl1 gene is 2,620 
base pairs, composed of two exons and one intron, while the protein is 231 amino acids 
long. Homo- or heterodimerization with other ubiquitously expressed bHLH proteins, 
such as E12 (Farah et al., 2000) and E47 (Massari and Murre, 2000), is necessary for 
efficient binding to an E box (CANNTG) of Ascl1 target gene promoters. The target 
genes of Ascl1 are transcription factors, such as NeuroD (Ma et al., 1996; Cau et al., 
1997), Math4C and Ngn1 (Cau et al., 1997), Dlx1 and Dlx2 (Yun et al., 2002; 
Schuurmans et al., 2004; Poitras et al., 2007), Tlx3 and Ptf1a (Mizuguchi et al., 2006), 
and Olig2 and Nkx2-2 (Sugimori et al., 2008). In addition, Ascl1 regulates proliferation 
and cell cycle exit genes, such as Cdk1, Cdc25b, Hipk2, and Prmt2 (Castro et al., 2011). 
Ascl1 expression is essential to progenitor cells of the central nervous system (CNS) and 
peripheral nervous system (PNS). Ascl1 is required for proper development and 
differentiation of olfactory sensory neurons (Guillemot et al., 1993; Cau et al., 1997), 
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pulmonary neuroendocrine cells (Borges et al., 1997; Ito et al., 2000), parafollicular cells 
(Lanigan et al., 1998), chromaffin cells (Huber et al., 2002), glomus cells (Kameda, 
2005), and oligodendrocytes (Petryniak et al., 2007). Overexpression of Ascl1 results in 
neuronal reprogramming from astrocytes (Berninger et al., 2007) and fibroblasts 
(Vierbuchen et al., 2010). Moreover, transfection of Ascl1 is sufficient to differentiate 
embryonic carcinoma cells into neurons (Polyak et al., 1994; Farah et al., 2000). Thus, 
Ascl1 gene is vital for the survival of the organism. 
 
 
1.3 Hypothesis 
 
Ascl1 plays a role in maternal hepatic adaptations to pregnancy. 
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CHAPTER 2. MATERIALS AND METHODS 
 
 
 
2.1 Mouse Models 
 
 
 
2.1.1 Animal care 
 
Mice were allowed free access to food and water. The animals were maintained 
on 12 hour/12hour light/dark cycle at 22±1°C. All of the animal experiments were 
operated in accordance with the National Institutes of Health Guide for the Care and Use 
of Laboratory Animals. Protocols for the care and use of animals were accepted by the 
Indiana University-Purdue University Indianapolis Animal Care and Use Committee. 
 
 
2.1.2 Ascl1flox/flox;R26rtTA/rtTA;tetO-cretg/- mice 
 
This mouse strain was generated to create an inducible Ascl1 knockout mouse 
model by sequential breeding of following mouse strains. 
B6.Cg-Gt(ROSA)26Sortm1(rtTA*M2)Jae/J mice (Stock #006965) were obtained from 
The Jackson Laboratory (Bar Harbor, ME). Genotyping was performed as per directions 
from the vendor. The following primers were used for genotyping R26 wild-type allele: 
forward 5’-AAAGTCGCTCTGAGTTGTTAT-3’ and reverse 5’-GGAGCGGGAGAAA
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TGGATATG-3’. Genotyping of R26 mutant allele was performed with the same forward 
primer as for the wild-type allele and the following reverse primer 5’-GCGAAGAGTTT 
GTCCTCAACC-3'. PCR conditions were 35 cycles of 94°C/30 sec; 65°C/1 min; 72°C/1 
min. The expected results for wild-type band is around 650 bp while mutant band is 340 
bp. 
B6.Cg-Tg(tetO-cre1Jaw/J mice (Stock #006234) were obtained from The Jackson 
Laboratory (Bar Harbor, ME). Genotyping was performed as per directions from the 
vendor. The following primers were used for genotyping internal positive control: 
forward 5’-CTAGGCCACAGAATTGAAAGATCT-3’ and reverse 5’-GTAGGTGGAA 
ATTCTAGCATCATCC-3’. Genotyping of transgene was performed with the following 
primers: forward 5’-GCGGTCTGGCAGTAAAAACTATC-3’ and reverse 5’-GTGAAA 
CAGCATTGCTGTCACTT-3’. PCR conditions were 35 cycles of 94°C/30 sec; 70°C/1 
min; 72°C/1 min. The expected results for internal positive control band is 324 bp while 
transgene band is around 100 bp. This assay does not distinguish between hemizygote 
from homozygote transgenic mice. 
Ascl1flox/flox;R26stopfloxYFP/stofloxYFP mice were generous gifts from Dr. Guillemot 
(MRC National Institute for Medical Research, Mill Hill, London). Genotyping was 
performed as per directions (Pacary et al., 2011) with modifications. The following 
primers were used for genotyping Ascl1 wild-type allele: forward 5’-CTACTGTCCAAA 
CGCAAAGTGG-3’ and reverse 5’-GCTCCCACAATCCTCGTAAAGA-3’. Genotyping 
of Ascl1 mutant allele was performed with the same forward primer as for the wild-type 
allele and the following reverse primer 5’-TAGACGTTGTGGCTGTTGTAGT-3'. PCR 
conditions were 35 cycles of 94°C/30 sec; 69°C/30 sec; 72°C/90 sec. The expected 
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results for wild-type band is 342 bp while mutant band is 857 bp. The following primers 
were used for genotyping R26 wild-type allele: forward 5’-AAAGTCGCTCTGAGTTGT 
TAT-3’ and reverse 5’-GGAGCGGGAGAAATGGATATG-3’. Genotyping of R26 
mutant allele was performed with the same forward primer as for the wild-type allele and 
the following reverse primer 5’-AAGACCGCGAAGAGTTTGTC-3’. PCR conditions 
were 35 cycles of 94°C/30 sec; 69°C/1 min; 72°C/1 min. The expected results for wild-
type band is 600 bp while mutant band is 320 bp. 
R26rtTA/rtTA mice were crossed with tetO-cretg/- mice to produce R26rtTA/rtTA;tetO-
cretg/- mice. The progenies were then bred with Ascl1flox/flox;R26stopfloxYFP/stofloxYFP mice. 
Since both Enhanced Yellow Fluorescent Protein (EYFP) and reverse tetracycline-
controlled transactivator (rtTA) genes occupied the same R26 promoter element, the 
EYFP gene was removed by artificial selection. Extensive selective breeding was 
performed to generate Ascl1 inducible knockout mice (Ascl1flox/flox;R26rtTA/rtTA;tetO-cretg/-) 
and wild-type control mice (Ascl1wt/wt;R26rtTA/rtTA;tetO-cretg/-). 
 
 
2.1.3 Ascl1flox/CreERT2;R26stopfloxYFP/stopfloxYFP mice 
 
This mouse strain was generated to create a conditional and inducible Ascl1 
knockout mouse model by sequential breeding of Ascl1tm1.1(Cre/ERT2)Jejo/J mice (Stock 
#012882) obtained from The Jackson Laboratory (Bar Harbor, ME). Genotyping was 
performed as per directions from the vendor. The following primers were used for 
genotyping Ascl1 wild-type allele: forward 5’-TCCAACGACTTGAACTCTATGG-3’ 
and reverse 5’-CCAGGACTCAATACGCAGGG-3’. Genotyping of Ascl1 mutant allele 
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was performed with the following primers: forward 5’-AACTTTCCTCCGGGGCTCGT 
TTC-3’ and reverse primer 5’-CGCCTGGCGATCCCTGAACATG-3'. Hotstart Taq 
polymerase was used for the assay. PCR conditions were 35 cycles of 94°C/30 sec; 
62°C/30 sec; 72°C/30 sec. The expected results for wild-type band is 418bp while mutant 
band is around 300 bp. Ascl1flox/flox;R26stopfloxYFP/stofloxYFP mice are described above in the 
same page. Ascl1Cre/+ mice were crossed with Ascl1flox/flox;R26stopfloxYFP/stofloxYFP mice. 
Selective breeding was performed to generate Ascl1 conditional and inducible knockout 
mice (Ascl1flox/CreERT2;R26stopfloxYFP/stopfloxYFP) and wild-type control mice 
(Ascl1flox/wt;R26stopfloxYFP/stopfloxYFP). 
 
 
2.2 Timed pregnancy 
 
Ascl1 inducible knockout and wild-type control female mice were bred with wild-type 
control male mice to ensure that fetuses have at least one Ascl1 gene after doxycycline 
treatment. Breeding cages were setup and the presence of a copulation plug in the vagina 
was considered as gestation day 1. Plug-positive female mice were housed separately 
from male mice. 
 
 
2.3 Tissue collection 
 
Pregnant mice were administered with doxycycline (1 mg/ml) in drinking water 
from gestation day 6 to 18. Mice were sacrificed by cervical dislocation and weighed. 
Livers were dissected and weighed. Liver tissues were fixed in formalin and sent to 
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Indiana University pathology core to be embedded in paraffin for histological analysis or 
snap-frozen in liquid nitrogen for total RNA isolation. 
 
 
2.4 Quantitative real-time polymerase chain reaction 
 
Total RNA was isolated from frozen liver tissue using TRIzol reagent according 
to the manufacturer’s protocol (Invitrogen, Carlsbad, CA). cDNA was synthesized from 
each sample using Verso cDNA kit (Thermo Scientific, Rockford, IL), diluted 4 times 
with water, and subjected to qRT-PCR to quantify mRNA levels. TaqMan Universal PCR 
Master Mix and Ascl1 TaqMan probe (Mm04207567_g1) were used from Applied 
Biosystems (Foster City, CA). The amplification reactions were carried out in the ABI 
Prism 7900 sequence detection system (Applied Biosystems, Foster City, CA) with initial 
hold steps (50°C for 2 minutes followed by 95°C for 10 minutes) and 40 cycles of a two-
step PCR (92°C for 15 seconds and 60°C for 1 minute). The comparative CT method was 
used for relative quantification of the amount of mRNA for each sample normalized to 
Albumin transcript levels. 
 
 
2.5 Hepatocyte density measurement 
 
Formalin-fixed and paraffin-embedded liver sections were stained with 
Hematoxylin and Eosin. Hepatocytes were counted with Image-Pro Plus software (Media 
Cybernetics, MD) in five microscope fields at 400x magnification. This technique was 
consistent for each sample. 
11 
2.6 Immunohistochemistry 
 
Formalin-fixed and paraffin-embedded liver sections were subjected to pan 
cadherin and HNF4α immunostaining for visualizing hepatic cell boundary and 
evaluating hepatocyte identity, respectively. Livers sectioned at 5 µm were 
deparaffinized and hydrated. Epitope retrieval was performed by placing the slides into 
boiling citrate buffer (10 mM, pH 6.0) for 30 minutes and cooled to room temperature for 
3 hours. Endogenous peroxidase activity was quenched using 3% H2O2 for 10 minutes. 
Sections were blocked with normal serum of the animal that the secondary antibody was 
raised for 1 hour at room temperature. Afterwards, sections were incubated with a 
primary antibody against pan cadherin (Cell Signaling, Cat #4068; 1:100) or HNF4α 
(Santa Cruz, Cat #sc-6556; 1:50) at 4°C overnight. On the following day, sections were 
incubated with respective biotinylated secondary antibody for 1 hour at room temperature, 
VECTASTAIN ABC Kit reagent for 30 minutes (Vector Laboratories, Burlingame, CA), 
and DAB Peroxidase Substrate Kit reagent (Vector Laboratories, Burlingame, CA) 
according to the manufacturer’s instructions. Sections were counterstained with 
hematoxylin, dehydrated, and mounted with coverslip. 
 
 
2.7 Immunofluorescence 
 
Formalin-fixed and paraffin-embedded liver sections were subjected to β-catenin 
immunofluorescence staining for visualizing nuclear localization in hepatic cells. Livers 
sectioned at 5 µm were deparaffinized, epitopes retrieved, endogenous peroxidase 
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quenched, and blocked as described above. Sections were incubated with a primary 
antibody against β-catenin (BD Transduction, Cat #610153; 1:20) at 4°C overnight. On 
the following day, sections were incubated with fluorescent-tagged secondary antibody 
(Jackson ImmunoResearch Laboratories, West Grove, PA) for 1 hour at room 
temperature in the dark. The slides were mounted using ProLong Gold Antifade 
Mountant with DAPI (Life Technologies, Carlsbad, CA) and examined under confocal 
microscopy (Olympus FluoView FV1000). 
 
 
2.8 Ascl1 mRNA in situ hybridization 
 
Livers of partially hepatectomized C57BL6 male mice and gestation day 11 CD1 
female mice were fixed in formalin, embedded in paraffin, and sectioned at 5 µm from 
Indiana University pathology core. In situ hybridization procedures for mouse Ascl1 
mRNA and Fast Red staining on the hybridized probes were performed by the RNAscope 
2.0 Formalin-Fixed, Paraffin-Embedded (FFPE) Assay (Advanced Cell Diagnostics, Inc., 
Hayward, CA) and a probe for mouse Ascl1 mRNA (NM_008553, Advanced Cell 
Diagnostics) according to the manufacturer’s instruction. Trial experiments using 
negative control DapB (dihydrodipicolinate reductase) and positive control Ppib 
(peptidylprolyl isomerase B) mRNAs were tested to determine the efficiency of the 
standardized protocol. 
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CHAPTER 3. RESULTS 
 
 
 
3.1 Identification of cells expressing Ascl1 mRNA in maternal liver during pregnancy 
 
To determine Ascl1-expressing cells in maternal liver, in situ hybridization was 
performed using Ascl1 mRNA probe on liver sections from nonpregnant, gestation day 
11, and gestation day 18 CD1 mice. Nonpregnant livers were negative for Ascl1 mRNA. 
In contrast, Ascl1 mRNA expression was widely distributed in pregnant livers, including 
parenchymal, nonparenchymal, and mesothelial cells (Figure 1). Within Ascl1-positive 
hepatic parenchymal cells, Ascl1 mRNA was predominantly located in the nucleus. The 
data demonstrate that Ascl1 mRNA is expressed in most cell types in maternal liver 
during gestation. 
 
 
3.2 Identification of cells expressing Ascl1 mRNA in regenerating liver 
 
To determine Ascl1-expressing cells in regenerating adult liver, in situ 
hybridization was performed using Ascl1 mRNA probe on liver sections from 2/3 
partially hepatectomized (PHx) C57BL/6J male mice. In normal liver, small populations 
of Ascl1-expressing cells were observed on outer edge and in periportal region. In 
regenerating liver, however, Ascl1-expressing cells were widely distributed in multiple 
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hepatic cell types (Figure 2). Until 24 hours after PHx, Ascl1-expressing cells only 
consisted small populations of liver cells. From 36 to 140 hours after PHx, most hepatic 
parenchymal, nonparenchymal, and mesothelial cells were expressing Ascl1 mRNA. By 
the end of liver regeneration (168 hours after PHx), Ascl1-expressing cells were mostly 
observed on outer edge and in periportal region. In addition, Ascl1 mRNA was primarily 
localized in the nuclei of hepatic cells. Thus, hepatic Ascl1 transcription is activated after 
PHx and most hepatic cell types express Ascl1 mRNA during liver regeneration. 
 
 
3.3 Study of global loss-of-function of Ascl1 
 
 
 
3.3.1 Generation of global inducible Ascl1 knockout mouse model 
 
A mouse strain (Ascl1flox/flox;R26rtTA/rtTA;tetO-cretg/-) was generated to study the 
function of Ascl1 (see Materials and Methods). This mouse strain carries loxP-flanked 
Ascl1 gene, reverse tetracycline-controlled transactivator (rtTA) gene under control of 
ubiquitous Rosa26 promoter element, and Cre recombinase gene under control of 
tetracycline-responsive promoter element. Administration of doxycycline activates rtTA, 
which drives Cre recombinase expression to delete Ascl1 gene (Figure 3). However, the 
cells in the brain and testis are not affected since doxycycline is unable to travel across 
the blood-brain and blood-testis barriers (Hochedlinger et al., 2005). A control mouse 
strain (Ascl1wt/wt;R26rtTA/rtTA;tetO-cretg/-) was also generated as a genetic control. In this 
mouse strain, Ascl1 gene lacks loxP sites, and thus, doxycycline treatment does not ablate 
Ascl1 gene. 
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3.3.2 Phenotype analysis of global inducible Ascl1 knockout 
 
 
 
3.3.2.1 Global inducible Ascl1 knockout causes maternal liver enlargement, litter size 
reduction, and fetal growth retardation 
 
To identify the phenotype from Ascl1 ablation, genetic control (WT) and Ascl1 
inducible knockout (KO) pregnant mice were treated with doxycycline in drinking water 
(1 mg/ml) from gestation day 6 (D6) until gestation day 18 (D18). On D18, the maternal 
livers and fetuses were collected and weighed. KO maternal livers had successfully 
deleted Ascl1 gene based on quantitative real-time polymerase chain reaction (qRT-PCR) 
(Figure 4). KO maternal livers showed 99% decrease in Ascl1 mRNA expression when 
compared to controls. Deletion of Ascl1 gene during gestation resulted in increased liver-
to-body weight ratio (5.4% in WT vs. 6.9% in KO), 35% decrease in litter size, and 18% 
decrease in fetal weight when compared to controls (Figure 5). These results indicated 
that Ascl1 is essential for normal pregnancy. 
 
 
3.3.2.2 Global ablation of Ascl1 causes abnormalities in maternal liver histology and 
nuclear translocation of β-catenin in maternal liver cells during gestation 
 
Due to abnormal size of maternal livers in Ascl1 KO mice, histological analysis 
was performed to gain insight into the phenotype. Hematoxylin and eosin (H&E) staining 
showed normal histological sections in WT livers while deficiency of cytosol around 
nuclei of hepatocytes in KO livers were observed (Figure 6). Morphologically, cell 
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boundaries were not readily apparent in KO livers in comparison to WT livers. However, 
pan cadherin staining result suggested normal cell-cell adhesion in liver parenchyma 
(Figure 7). In addition, hepatocytes showed positive hepatocyte nuclear factor 4 alpha 
(HNF4α) nuclear staining regardless of genotype (Figure 8). This observation suggested 
hepatocyte identity was not impaired with Ascl1 ablation. Interestingly, β-catenin was 
weakly detected in the nucleus of WT liver cells (Figure 9). In contrast, the nuclear β-
catenin was abundant in the nucleus of KO liver cells. Therefore, ablation of Ascl1 gene 
resulted in nuclear translocation of β-catenin. Taken together, Ascl1 ablation resulted in 
changes at molecular, cellular, and organ levels in the maternal livers. 
 
 
3.4 Study of cell-specific loss-of-function of Ascl1 
 
 
 
3.4.1 Generation of cell-specific conditional and inducible Ascl1 knockout mouse model 
 
A mouse strain (Ascl1flox/CreERT2;R26stopfloxYFP/stopfloxYFP) was generated to study the 
function of Ascl1 (see Materials and Methods). This mouse strain carries loxP-flanked 
Ascl1 gene, loxP-flanked STOP sequence followed by Enhanced Yellow Fluorescent 
Protein gene (EYFP) under control of Rosa26 promoter element, and Cre recombinase 
gene under control of Ascl1 promoter element. Ascl1-expressing cells produce Cre 
recombinase, which ablates Ascl1 gene and STOP sequence with the administration of 
tamoxifen (Figure 10). As a result, Ascl1-expressing cells ablates Ascl1 while 
permanently being labeled with EYFP. A control mouse strain 
(Ascl1CreERT2/wt;R26stopfloxYFP/stopfloxYFP) was also generated. In this mouse strain, Ascl1 
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gene lacks loxP sites, and thus, tamoxifen treatment does not ablate Ascl1. This control 
mouse strain can be used to label Ascl1-expressing cells with EYFP and study the faith of 
these cells when tamoxifen is administered. In KO mouse strain, Ascl1-expressing cells 
are labeled with EYFP and Ascl1 gene is deleted with administration of tamoxifen. Thus, 
in this mouse strain, the effect of Ascl1 ablation in Ascl1-expressing cells can be 
evaluated. The mouse strains have been primarily evaluated for phenotypes. Preliminary 
study indicates enlargement of maternal liver as seen with doxycycline mouse model. 
Currently, the expansion of the two colonies is in process. 
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CHAPTER 4. DISCUSSION 
 
 
 
We demonstrate for the first time that pregnant and regenerating liver activates 
Ascl1 transcription. In maternal livers, previous RT-PCR analysis showed that expression 
of Ascl1 mRNA begins from gestation day 8 to the end of pregnancy (unpublished data). 
Here, we demonstrate by in situ hybridization that multiple cell types (parenchymal, 
nonparenchymal, and mesothelial cells) in maternal liver express Ascl1. During liver 
regeneration, multiple hepatic cell types express Ascl1 from 36 to 168 hours after PHx. 
During development, progenitor cells in central nervous system (CNS) and peripheral 
nervous system (PNS) express Ascl1, including neuroblasts (Tomita et al., 2000), 
telencephalic progenitor cells (Casarosa et al., 1999; Parras et al., 2002; Yun et al., 2002), 
oligodendrocyte precursor cells (Petryniak et al., 2007), late dorsal precursor cells 
(Mizuguchi et al., 2006), olfactory receptor neuron progenitor cells (Cau et al., 1997; 
Murray et al., 2003; Krolewski et al., 2012), retinal progenitor cells (Tomita et al., 1996, 
2000; Hatakeyama et al., 2001; Nelson et al., 2009), pulmonary neuroendocrine 
progenitor cells (Borges et al., 1997), and gastric neuroendocrine progenitor cells 
(Kokubu et al., 2008). In adult mice, pituitary and microglia express Ascl1 
(www.BioGPS.org). Moreover, neuroendocrine tumors, such as small cell lung cancers 
(Ball, 2004), medullary thyroid cancers (Chen et al., 2005), gastroenteropancreatic 
neuroendocrine tumors (Shida et al., 2008), and prostate cancers (Vias et al., 2008), also 
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express Ascl1. Our findings link Ascl1 gene with liver growth in both physiological and 
pathological conditions in adult animals. 
Notably, hepatic mesothelial cells abundantly express Ascl1 during pregnancy and 
liver regeneration. During liver fibrogenesis, hepatic mesothelial cells expressing Wilms 
tumor 1 undergo mesothelial-mesenchymal transition to generate hepatic stellate cells 
and myofibroblasts (Li et al., 2013), indicating mesothelial cells as one type of liver 
progenitor cells. In addition, a small area of mesothelium in mouse ovary contains a stem 
cell niche of the ovarian surface epithelium (Flesken-Nikitin et al., 2013). Based on these 
two reports, we strongly believe that hepatic mesothelial cells are potentially liver 
progenitor cells expressing Ascl1 during pregnancy and liver regeneration. Further 
studies are needed to determine this. 
We also demonstrate that the mouse model efficiently ablates Ascl1 gene during 
gestation, and results in maternal liver enlargement, litter size reduction, and fetal growth 
retardation. In addition, maternal hepatocytes deficient in Ascl1 gene lack majority of 
their cytosols while maintaining their cellular boundary and identity. The functions of 
Ascl1 in nervous system have been intensively investigated. Ascl1 regulates proliferation, 
cell cycle exit, and differentiation during neurogenesis. Ascl1 promotes progenitor 
divisions by positively regulating G1/S transition and entry into mitosis (Castro et al., 
2006, 2011). Moreover, Ascl1 terminates proliferation of progenitors by targeting cell 
cycle arrest genes, such as Ccng2, Fbxw7, and Gadd45g, during late phase of 
neurogenesis (Farah et al., 2000; Nakada et al., 2004; Castro et al., 2011). Finally, Ascl1 
acts on differentiation and maturation of progenitor cells by regulating downstream 
neural transcription factors, including Dlx2, Ebf3, and Gli3 (Anderson et al., 1997; 
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Kuschel et al., 2003; Steele-Perkins et al., 2005; Bergsland et al., 2006; Zhao et al., 2006; 
Petryniak et al., 2007). Hence, Ascl1 has roles in all stages of neurogenesis. The 
phenotype of Ascl1 gene deletion during gestation indicate its essential roles in 
maintaining normal pregnancy. The functions of Ascl1 during pregnancy and liver 
regeneration require further investigations. The animal models that we have generated 
have proven to be a useful in vivo approach to pursue this goal. 
Prior to parturition, maternal livers of Ascl1 knockout mice showed accumulation 
of β-catenin in the nuclei of hepatocytes. β-catenin, a transcription factor, is a critical 
component in embryonic development and stem cell maintenance. Normally restricted in 
cell adhesion complex, β-catenin undergo phosphorylation by casein kinase 1 (CK1) and 
glycogen synthase kinase 3 (GSK3), ubiquitination, and degradation by proteasomes 
(Moon et al., 2004). When Wnt signaling pathway is active, β-catenin degradation 
decreases, accumulates in cytosol, translocates into cell nucleus, and interacts with T-cell 
factor (TCF) and lymphoid enhancer-binding protein (LEF) transcription factors to 
initiate activation of β-catenin target genes, such as neurogenin 1 (Hirabayashi et al., 
2004), NeuroD1 (Kuwabara et al., 2009), cyclin D1, and EGF receptor (Tan et al., 2005). 
β-catenin also regulates liver homeostasis and regeneration (Monga et al., 2001). Both β-
catenin knockdown and knockout suppress hepatocyte proliferation and delay liver 
regeneration after PHx (Sodhi et al., 2005; Tan et al., 2006). In addition, Wnt/β-catenin 
pathway regulates differentiation of liver progenitor cells into hepatocytes (Boulter et al., 
2012). β-catenin nuclear translocation in Ascl1 knockout liver strongly suggests that 
Ascl1 genetic deletion results in the activation of Wnt/β-catenin pathway in hepatocytes. 
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This provides an important clue to understand how Ascl1 exerts its regulatory effects in 
pregnant liver and, potentially, regenerating liver. 
In summary, both maternal liver during pregnancy and regenerating liver after 
PHx induce expression of Ascl1 in most hepatic cell types. Ascl1 gene is essential for the 
progression of normal pregnancy. Mesothelial cells are potential origin of Ascl1-
expressing cells. Future direction includes further identification of hepatic Ascl1-
expressing cells, isolation and characterization of hepatic Ascl1-expressing cells, and 
further Ascl1 functional studies. 
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FIGURES 
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Figure 1. In situ hybridization for Ascl1 mRNA in maternal liver during gestation. 
Nonpregnant (NP), gestation day 11 (D11), and gestation day 18 (D18) CD1 mouse livers 
were isolated, formalin-fixed, paraffin-embedded, and sectioned. In situ hybridization for 
Ascl1 mRNA was performed using Fast Red from RNAscope 2.0 HD Assay, labeling the 
probe with red dye. Note that Ascl1 mRNA is absent for NP liver but is present in 
parenchymal (black arrow), nonparenchymal (blue arrow), and mesothelial (yellow arrow) 
cells in pregnant liver. 
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Figure 2. In situ hybridization for Ascl1 mRNA in regenerating liver. Regenerating 
livers of 2/3 partially hepatectomized (PHx) male mice were isolated at the indicated time 
points after PHx, formalin-fixed, paraffin-embedded, and sectioned. In situ hybridization 
for Ascl1 mRNA was performed using Fast Red from RNAscope 2.0 HD Assay, labeling 
the probe with red dye. Note that hepatic parenchymal (black arrow), nonparenchymal 
(blue arrow), and mesothelial (yellow arrow) cells express Ascl1 during liver regeneration. 
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Figure 2, continued. 
33 
 
Figure 2, continued. 
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Figure 3. Ascl1 global inducible knockout mouse model. In Ascl1flox/flox;R26rtTA/rtTA; 
tetO-cretg/- mouse strain, ubiquitous Rosa26 promoter element (Rosa26 locus) drives the 
expression of reverse tetracycline-controlled transactivator gene (rtTA). Doxycycline 
(Dox) administration activates rtTA, which in turns binds to tetracycline-responsive 
promoter element (tetO locus) to transactivate Cre recombinase gene. Cre recombinase 
floxes out loxP-flanked Ascl1 gene. As a result, Ascl1 is ablated by doxycycline treatment. 
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Figure 4. Ascl1 mRNA expression in maternal liver during pregnancy. Nonpregnant 
(NP) and timed pregnancy was generated on genetic control (Ascl1wt/wt;R26rtTA/rtTA;tetO-
cretg/-; WT) and global inducible Ascl1 knockout (Ascl1flox/flox;R26rtTA/rtTA;tetO-cretg/-; KO) 
mice. Doxycycline in drinking water (1 mg/ml) was administered to pregnant mice from 
gestation day 6 to18. On gestation day 18, maternal livers were collected and weighed. 
Hepatic mRNA levels of Ascl1 were measured by qRT-PCR and are expressed as the 
mean fold changes relative to NP controls (± s.d.; n=3-4. *, P<0.05). 
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Figure 5. Phenotype from Ascl1 ablation. Maternal livers and fetuses were collected 
and weighed from genetic control (WT) and KO mice (described in Figure 4) on 
gestation day 18. Maternal liver-to-body weight ratio (A), litter size (B), and fetal weight 
(C) are presented. The data are expressed as the means ± s.d.; n=3-4. *, P<0.05. 
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Figure 5, continued. 
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Figure 6. H&E staining of maternal liver. Maternal livers were collected from genetic 
control (WT) and KO mice (described in Figure 4) on gestation day 18, fixed in formalin, 
and embedded in paraffin. H&E staining was performed. Note the lack of cytosol around 
nuclei of hepatocytes and indistinct cellular boundaries in pregnant KO livers. 
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Figure 7. Pan cadherin immunostaining. Maternal livers were collected from genetic 
control (WT) and KO mice (described in Figure 4) on gestation day 18, fixed in formalin, 
and embedded in paraffin. Pan cadherin immunostaining was performed. No overt 
differences in cell-cell junction between WT and KO maternal livers were observed. 
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Figure 8. Hepatocyte nuclear factor 4 alpha (HNF4α) immunostaining. Maternal 
livers were collected from genetic control (WT) and KO mice (described in Figure 4) on 
gestation day 18, fixed in formalin, and embedded in paraffin. HNF4α immunostaining 
was performed. HNF4α was positive in nuclei of hepatocytes in both WT and KO 
maternal livers. 
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Figure 9. β-catenin immunofluorescence staining. Maternal livers were collected from 
genetic control (WT) and KO mice (described in Figure 4) on gestation day 18, fixed in 
formalin, and embedded in paraffin. β-catenin immunofluorescence staining was 
performed. Note the increased nuclei translocation of β-catenin in KO livers compared to 
controls (400x magnification). 
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Figure 10. Ascl1 cell-specific conditional and inducible knockout mouse model. In 
Ascl1flox/CreERT2;R26stopfloxYFP/stopfloxYFP mouse strain, Ascl1 promoter element (Ascl1 locus) 
drives the expression of Cre recombinase gene. Tamoxifen administration activates Cre 
recombinase, which in turns floxes out loxP-flanked Ascl1 gene and loxP-flanked STOP 
sequence. As a result, Ascl1 is specifically ablated in Ascl1-expressing cells by tamoxifen 
treatment. 
